Luo Xi, Pang Zherui, Li Jinhua, Anh Minjun, Kim Byoung Soo, Gao Ge
School of Medical Technology, Beijing Institute of Technology, Beijing 100081, China.
School of Medical Technology, Beijing Institute of Technology, Zhengzhou Academy of Intelligent Technology, Zhengzhou 450000, China.
iScience. 2024 Oct 19;27(11):111215. doi: 10.1016/j.isci.2024.111215. eCollection 2024 Nov 15.
Arterial disorders such as atherosclerosis, thrombosis, and aneurysm pose significant health risks, necessitating advanced interventions. Despite progress in artificial blood vessels and animal models aimed at understanding pathogenesis and developing therapies, limitations in graft functionality and species discrepancies restrict their clinical and research utility. Addressing these issues, bioengineered arterial equivalents (AEs) with enhanced vascular functions have been developed, incorporating innovative technologies that improve clinical outcomes and enhance disease progression modeling. This review offers a comprehensive overview of recent advancements in bioengineered AEs, systematically summarizing the bioengineered technologies used to construct these AEs, and discussing their implications for clinical application and pathogenesis understanding. Highlighting current breakthroughs and future perspectives, this review aims to inform and inspire ongoing research in the field, potentially transforming vascular medicine and offering new avenues for preclinical and clinical advances.
动脉疾病,如动脉粥样硬化、血栓形成和动脉瘤,会带来重大的健康风险,因此需要先进的干预措施。尽管在人工血管和动物模型方面取得了进展,旨在了解发病机制和开发治疗方法,但移植物功能的局限性和物种差异限制了它们在临床和研究中的应用。为了解决这些问题,已经开发出具有增强血管功能的生物工程动脉等效物(AE),采用了创新技术,改善了临床结果并增强了疾病进展建模。本综述全面概述了生物工程AE的最新进展,系统总结了用于构建这些AE的生物工程技术,并讨论了它们对临床应用和发病机制理解的意义。突出当前的突破和未来前景,本综述旨在为该领域正在进行的研究提供信息并激发灵感,有可能改变血管医学,并为临床前和临床进展提供新途径。